Nissan Motor (OTC:NSANY) plans to cease vehicle production at its Wuhan plant in China by the end of its current business year, which concludes on March 31, 2026, according to a report from Yomiuri newspaper citing unidentified sources. The move follows a sharp decline in production efficiency, with the plant operating at less than 10% of its 300,000-vehicle annual capacity. The Wuhan facility, leased from Dongfeng Motor since 2022, manufactures models including the Ariya electric vehicle and the X-Trail SUV.
The competitive pressure from rapidly growing Chinese automakers has significantly impacted Nissan’s performance in the region. Nissan declined to comment on the reported shutdown. Meanwhile, the Japanese automaker forecast a record net loss of 700 billion to 750 billion yen ($4.87 billion to $5.22 billion) for the fiscal year ended March 2025, largely due to massive impairment charges.
The struggling Wuhan plant reflects the broader challenges facing foreign automakers in China’s intensely competitive auto market, particularly in the EV sector where domestic brands are gaining dominance. Nissan’s strategic retreat underscores the shifting dynamics as global carmakers recalibrate operations to adapt to China's evolving automotive landscape.


United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 



